ATX-30
Asset
Activates the AMPK network.
- Stage
- Human trials
- Modality
- Not known
- Target
- Not known
- 2
- Indications
- 0
- Trials
- 1
- Developer
Indications
2Cardiometabolic disease
Human trials, cambrianbio.com, 10 Oct 2026
Obesity
Human trials, cambrianbio.com, 10 Oct 2026
In the full profile
- Owner and partners1
Every asset’s record: target, stage, trials and the evidence behind it.